This article is provided for educational and informational purposes only. All compounds discussed are supplied strictly for laboratory and research use. Vitro Labs products are not for human or animal consumption.
This article is provided for educational and informational purposes only. All compounds discussed are supplied strictly for laboratory and research use. Vitro Labs products are not for human or animal consumption.
A Certificate of Analysis is the most important document a research-grade compound ever ships with. It is also the document most researchers glance at and file away without really reading. That is a problem, because the COA is where the supplier’s quality claims either hold up under scrutiny or quietly fall apart. A COA tells the receiving laboratory three things: what the compound actually is, how pure it actually is, and how much of it is actually in the vial. Each of those three answers depends on a specific analytical method, and each method has limits a careful researcher should understand before using a compound in a controlled experiment.
This walkthrough takes a Vitro Labs Certificate of Analysis section by section and explains what each line means, what method produced it, and what the value should look like for a research-grade compound. Every Vitro batch is verified by Freedom Diagnostics, an ISO-certified independent analytical laboratory, with batch-specific identity and purity testing performed before release. The article is for laboratory research use only and assumes a reader already operating in a research environment.
A Certificate of Analysis is a document, issued either by a manufacturer or by a third-party analytical laboratory, that records the results of specific tests performed on a specific batch of a specific compound. The key word is specific. A COA is not a brochure. It is not a marketing PDF that describes what the product is supposed to be. It is a record of measurements taken on a particular lot of material, traceable to a date, an instrument, and an analyst.
For research-grade compounds, the analytical methods on a credible COA are well-established in the analytical chemistry literature. High-performance liquid chromatography for purity, mass spectrometry for identity, and gravimetric or amino-acid-analysis methods for quantity have been the standard for decades. Rivier and colleagues described the use of HPLC for synthetic compound characterization in detail (PMID: 4030099), and the methods have been refined continuously since then.
The reason a research-grade COA matters is straightforward. Independent testing of the research-grade compound market has repeatedly found compounds that do not match their labels, with reported failure rates in the 30 to 40 percent range across various surveys of the gray market. A real COA, issued by an independent lab, is the only document that distinguishes a verified batch from a vial of unknown content.
A COA does not certify that a compound is safe for any particular use. It does not certify regulatory approval. It is a record of analytical findings on a specific batch. Vitro Labs products are research compounds, not approved for human consumption, and the COA is a research-quality document, not a clinical or therapeutic credential.
Every Vitro Labs COA opens with a header block that contains the basic identifiers. These look mundane, but they are the part of the document that ties every downstream measurement to a single physical batch.
The compound name is given in full, with any common abbreviations in parentheses. Below it, on most COAs for synthetic compounds, the amino acid sequence appears in single-letter code. For a compound like BPC-157, that sequence is GEPPPGKPADDAGLV, which is the 15-residue 15-amino-acid compound first characterized by Sikiric and colleagues from a partial sequence of human gastric juice protein. The sequence on the COA should match the published sequence in the primary literature exactly. If it does not, the document is either describing a different compound or contains a typographical error worth flagging.
The batch number is the unique identifier for the production run. Every vial from that run shares the same batch number, and every COA for that run carries the same number. This is the anchor that lets a receiving laboratory verify that the COA in hand corresponds to the vial on the bench. A COA without a batch number is functionally useless because there is no way to tie it to a physical product.
The manufacture date marks when the compound was synthesized and lyophilized. The test date marks when Freedom Diagnostics performed the analytical work. For lyophilized compounds stored at minus 20 degrees Celsius, stability is generally measured in years, but a researcher should still note both dates and confirm that the testing was recent relative to the manufacture date.
The identity section answers the question: is this compound actually what the label says it is? The standard method is mass spectrometry, usually electrospray ionization mass spectrometry, abbreviated ESI-MS.
Every compound has a theoretical molecular mass calculated from its amino acid sequence. For a large metabolic analog, that theoretical mass is 4813.45 daltons, derived from the published structure described by Coskun and colleagues in their 2018 characterization paper (PMID: 30293770). The mass spectrometer ionizes the sample and measures the mass-to-charge ratio of the resulting ions, which can be back-calculated to a molecular mass. A match between the observed mass and the theoretical mass, typically within a tolerance of plus or minus one dalton for routine characterization, confirms that the compound in the vial has the molecular weight expected for the labeled compound.
A Vitro COA includes either the numerical mass result or, for compound deep-dives, the mass spectrum itself. The spectrum shows a series of peaks corresponding to different charge states of the same molecule. The deconvoluted mass, which collapses those charge states back to a single molecular weight, is what should match the theoretical value. If the deconvoluted mass is off by more than a few daltons, that is a signal of either a synthesis error, a contaminating species, or a mislabeled compound.
⚗️ Research Disclaimer: All content on this page is intended exclusively for licensed researchers, academic institutions, and scientific professionals operating within approved laboratory settings. The compounds and analytical methods discussed are described in a research context only. This content does not constitute medical advice, clinical guidance, or a recommendation for use in humans or animals outside of approved research protocols.
Purity is what most researchers look at first, and for good reason. A compound that is the right molecule but only 60 percent pure is a different research material than the same compound at 99 percent. The standard analytical method is reversed-phase high-performance liquid chromatography, abbreviated RP-HPLC.
HPLC works by passing a dissolved sample through a column packed with a stationary phase, then eluting it with a mobile-phase gradient. Different molecules interact with the stationary phase differently and exit the column at different times. A detector, usually a UV detector at 214 or 220 nanometers for compounds, records the amount of material exiting the column over time. The result is a chromatogram with peaks. Each peak is a distinct molecular species. The main peak corresponds to the target compound. Smaller peaks correspond to impurities. Hancock and Harding described the foundational application of RP-HPLC to compound analysis (PMID: 6526690), and the technique remains the workhorse of compound quality control.
The purity number on the COA is calculated as the area under the main peak divided by the total area under all peaks, expressed as a percentage. A research-grade compound should be at least 98 percent pure by HPLC. Vitro batches typically come in at 98 to 99 percent or higher. Anything reported below 95 percent is unusual for a synthetic compound intended for research and should be examined closely.
One important caveat. HPLC purity is method-dependent. A compound that elutes as a single peak under one set of column and gradient conditions may resolve into two peaks under different conditions. This is why a credible COA specifies the column, the mobile phase, the gradient, and the detection wavelength. It is also why ISO-accredited laboratories follow validated methods for each specific compound rather than running every compound on the same generic gradient.
Quantity is the section most easily misread. The label on a vial typically gives a total mass, for example 20 milligrams. The COA should specify whether that mass is total content or net compound content.
A lyophilized compound vial contains the compound itself plus residual counterions, typically trifluoroacetate (TFA) from the synthesis purification, and sometimes residual water. The net compound content is the mass of the actual compound, exclusive of those non-compound components. Net compound content is generally measured by amino acid analysis or by quantitative HPLC against a reference standard. The number is typically reported as a percentage, for example 85 percent net compound content, meaning that 85 percent of the total vial mass is the target compound and 15 percent is counterions, salts, and water.
For preclinical research where reconstitution math matters, the difference between total mass and net compound content is the difference between an accurate concentration and a systematically off-target one. A vial labeled 20 milligrams with 85 percent net compound content contains 17 milligrams of actual compound. Calculations that assume 20 milligrams will be off by 15 percent. A research-grade COA states net compound content explicitly. If a COA only reports total mass without specifying net compound content, that is a gap.
Below the analytical sections, a COA records physical specifications. These are simple but useful.
Lyophilized research-grade compounds should appear as white to off-white powders or cakes. A lyophilized compound that is yellow, gray, or visibly inhomogeneous indicates either a synthesis problem or degradation. The COA records the appearance at the time of testing. The receiving laboratory should compare that record to what is actually in the vial on receipt.
The COA may note solubility in standard reconstitution diluents. Most research-grade compounds are soluble in bacteriostatic water or sterile water, with some hydrophobic compounds requiring small amounts of acetic acid or DMSO for full dissolution. The solubility note is a research-procedure reference, not a directive to the reader.
Sterility and endotoxin testing are not run on every batch of every research-grade compound. They are typically run on a scheduled basis or for compounds where downstream research applications make those parameters relevant.
Sterility testing confirms the absence of viable microbial contamination. The standard method involves inoculating sample aliquots into nutrient broth and incubating for a defined period to detect any growth. A sterile result is reported as no growth observed.
Endotoxin testing measures bacterial endotoxin, specifically lipopolysaccharide from gram-negative bacterial cell walls, using the Limulus Amebocyte Lysate assay. Endotoxin is reported in endotoxin units per milligram of compound. For research applications where endotoxin would confound results, low endotoxin batches are required. The COA notes the assay result against a defined specification.
The single most important quality signal on a Certificate of Analysis is the name of the laboratory that performed the testing. A COA produced by the manufacturer’s own quality control department is not the same document as a COA produced by an independent third-party laboratory.
An independent laboratory has no commercial interest in the outcome of the analysis. The lab is paid to run the methods and report the results, regardless of whether those results pass or fail the manufacturer’s specifications. ISO certification, specifically ISO/IEC 17025 for testing laboratories, adds a documented quality management system on top of that independence. Methods are validated, instruments are calibrated to traceable standards, analysts are competency-tested, and the entire process is auditable.
Vitro Labs batches are tested by Freedom Diagnostics in Franklin, Tennessee. The batch-specific COA from Freedom Diagnostics is provided with every order, and the public Certificates of Analysis page maintains a record of recent batch results.
A few patterns on a COA should prompt additional scrutiny before the compound is used in research.
A COA that lacks a specific batch number, that uses a generic compound description rather than a specific batch identifier, or that appears to have been issued months or years before the labeled manufacture date is a document that does not actually correspond to the vial in hand.
A purity value of 99 percent without specifying the HPLC column, gradient, and detection wavelength is a number without a method. The method matters. Two laboratories running the same sample under different conditions can report different purity values. A credible COA documents the method.
A COA issued by the manufacturer’s own quality control department is acceptable for many industrial applications, but for research-grade compounds where the gray market includes a meaningful fraction of mislabeled compounds, an independent third-party laboratory is the stronger quality signal. Self-issued COAs can be accurate, but they cannot be independently verified without an outside check.
A purity number alone, without an identity confirmation by mass spectrometry, leaves open the possibility that the compound is the wrong molecule at high purity. Both identity and purity are needed. A COA that reports one without the other is incomplete.
HPLC purity measures the percentage of total UV-absorbing material that elutes as the main peak corresponding to the target compound. The number is calculated as the area under the main peak divided by the total area under all detected peaks. Hancock and Harding described the foundational application of reversed-phase HPLC to compound analysis (PMID: 6526690). One important limit: HPLC purity is method-dependent, so the COA should specify the column, mobile phase, gradient, and detection wavelength. A research-grade compound should be at least 98 percent pure by HPLC, and Vitro batches are tested for laboratory research use only.
Total mass is the entire mass of material in the lyophilized vial, including the compound itself plus residual counterions like trifluoroacetate from synthesis purification, plus any residual water. Net compound content is the mass of the actual target compound, exclusive of those non-compound components. The difference can be 10 to 20 percent. A vial labeled 20 milligrams with 85 percent net compound content contains 17 milligrams of actual compound. For preclinical research where concentration accuracy matters, net compound content is the relevant number, and a credible COA reports it explicitly. This applies to all research compounds for laboratory research use only.
Mass spectrometry confirms the identity of the compound by measuring its molecular mass and comparing that measurement to the theoretical mass calculated from the published amino acid sequence. For example, a large metabolic analog has a theoretical mass of 4813.45 daltons based on the structure described by Coskun and colleagues (PMID: 30293770). A match within routine analytical tolerance confirms that the molecule in the vial has the expected molecular weight. Without an identity confirmation, a high HPLC purity number could still describe the wrong molecule at high purity. Both identity and purity are needed for a complete research-grade characterization.
ISO certification, specifically ISO/IEC 17025 for testing and calibration laboratories, is an internationally recognized standard for laboratory quality management. A certified laboratory operates under documented procedures for method validation, instrument calibration to traceable reference standards, analyst competency assessment, and audit trails for every test performed. Vitro Labs batches are tested by Freedom Diagnostics, an ISO-certified independent analytical laboratory in Franklin, Tennessee. Independent ISO-certified testing is a stronger quality signal than self-issued manufacturer COAs because the testing laboratory has no commercial interest in the outcome. All Vitro products are not approved for human consumption and are supplied for laboratory research use only.
The test date marks when the analytical work was performed on the batch. For freshly manufactured lyophilized compounds, the test date should be close to the manufacture date, typically within weeks. For older batches, periodic retesting is sometimes performed to confirm continued specification compliance, since lyophilized compounds stored at minus 20 degrees Celsius are generally stable for years. A receiving research laboratory should note both the manufacture date and the test date on the COA and confirm that the testing was conducted on the same batch as the physical material in hand. Batch-specific traceability is the foundation of research models that depend on consistent compound quality.
⚗️ Research Disclaimer: All content on this page is intended exclusively for licensed researchers, academic institutions, and scientific professionals operating within approved laboratory settings. The compounds and analytical methods discussed are described in a research context only. This content does not constitute medical advice, clinical guidance, or a recommendation for use in humans or animals outside of approved research protocols.
